DAHL TERRENCE C.,HUSSAIN MUNIR A.,LIPPER ROBERT A.,JERZEWSKI ROBERT L.,MENNING MARK M.,OLIYAI REZA,YANG TAIYIN,Dahl Terrence C.,Hussain Munir A.,Lipper Robert A.,Jerzewski Robert L.,Menning Mark M.,Oliyai Reza,YA
申请号：
SI200631927
公开号：
SI2386294T1
申请日:
2006.06.13
申请国别(地区):
SI
年份:
2015
代理人:
摘要：
In accordance with this invention a novel pharmaceutical product containing efavirenz, emtricitabine and tenofovir DF are provided as a multicomponent unitary oral dosage form, component 1 comprising tenovofir DF (and, optionally, emtricitabine) and component 2 comprising efavirenz, wherein components 1 and 2 are in a stabilizing configuration. In preferred embodiments component 1 is made by dry granulation. In another embodiment a composition comprising tenovofir DF and a surfactant is claimed.
